Insight Brief
Cutting Time, Not Corners
Accelerating clinical entry through regulatory efficiency
Apr 20, 2026
Download

In today’s environment, regulators welcome targeted, phase-appropriate packages (the ‘right studies at the right time’) provided the rationale is well supported and include explicit patient safety protections. This Insights Guide outlines a science-driven strategy to evaluate non-clinical and clinical regulatory study requirements that helps to eliminate redundancies, right-size evidence packages, and adopt phase-appropriate, risk-based testing.

Related solutions

Contact Us